Interpretation or misinterpretation of clinical trials on septic shock: about the ANDROMEDA-SHOCK trial.
作者信息
Dépret François, Coutrot Maxime
机构信息
Department of Anesthesiology and Critical Care and Burn Unit AP-HP, GH Saint Louis-Lariboisière, Paris, France.
UMR INSERM 942, Institut National de la Santé et de la Recherche Médicale (INSERM), F-CRIN, INI-CRCT network, Paris, France.
出版信息
Ann Transl Med. 2020 Jun;8(12):800. doi: 10.21037/atm.2020.01.29.
Abstract
摘要
相似文献
1
Interpretation or misinterpretation of clinical trials on septic shock: about the ANDROMEDA-SHOCK trial.脓毒性休克临床试验的解读或误读：关于ANDROMEDA-SHOCK试验
Ann Transl Med. 2020 Jun;8(12):800. doi: 10.21037/atm.2020.01.29.
2
Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.以外周灌注状态为目标的复苏策略与脓毒性休克患者血清乳酸水平的影响。ANDROMEDA-SHOCK 试验的贝叶斯再分析。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):423-429. doi: 10.1164/rccm.201905-0968OC.
3
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.以外周灌注状态为目标的复苏策略与血清乳酸水平对感染性休克患者 28 天死亡率的影响：ANDROMEDA-SHOCK 随机临床试验。
JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071.
4
A lactate-targeted resuscitation strategy may be associated with higher mortality in patients with septic shock and normal capillary refill time: a post hoc analysis of the ANDROMEDA-SHOCK study.对于脓毒性休克且毛细血管再充盈时间正常的患者，乳酸靶向复苏策略可能与更高的死亡率相关：ANDROMEDA-SHOCK研究的事后分析
Ann Intensive Care. 2020 Aug 26;10(1):114. doi: 10.1186/s13613-020-00732-1.
5
Early goal-directed therapy using a physiological holistic view: the ANDROMEDA-SHOCK-a randomized controlled trial.采用生理整体观的早期目标导向治疗：ANDROMEDA-SHOCK随机对照试验。
Ann Intensive Care. 2018 Apr 23;8(1):52. doi: 10.1186/s13613-018-0398-2.
6
Diastolic shock index and clinical outcomes in patients with septic shock.脓毒性休克患者的舒张期休克指数与临床结局
Ann Intensive Care. 2020 Apr 16;10(1):41. doi: 10.1186/s13613-020-00658-8.
7
Control groups in recent septic shock trials: a systematic review.近期脓毒症休克试验中的对照组：一项系统性综述。
Intensive Care Med. 2016 Dec;42(12):1912-1921. doi: 10.1007/s00134-016-4444-y. Epub 2016 Jul 23.
8
Is There an Optimum Duration of Fluid Bolus in Pediatric Septic Shock? A Critical Appraisal of "Fluid Bolus Over 15-20 Versus 5-10 Minutes Each in the First Hour of Resuscitation in Children With Septic Shock: A Randomized Controlled Trial" by Sankar et al (Pediatr Crit Care Med 2017; 18:e435-e445).小儿感染性休克时液体复苏的最佳输液时间是多久？对 Sankar 等人发表的《小儿感染性休克患者复苏的前 1 小时内，与每次输液 5-10 分钟相比，15-20 分钟输液的效果：一项随机对照试验》一文的批判性评价（儿科危重病医学 2017；18:e435-e445）
Pediatr Crit Care Med. 2018 Apr;19(4):369-371. doi: 10.1097/PCC.0000000000001459.
9
Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates.不明原因的脓毒性休克试验死亡率差异：人群特征和对照组死亡率的系统分析。
Intensive Care Med. 2018 Mar;44(3):311-322. doi: 10.1007/s00134-018-5134-8. Epub 2018 Mar 15.
10
When data interpretation should not rely on the magnitude of P values: the example of ANDROMEDA SHOCK trial.当数据解读不应依赖P值大小时：以仙女座休克试验为例
Ann Transl Med. 2020 Jun;8(12):802. doi: 10.21037/atm.2020.01.49.
引用本文的文献
1
[The ROSE concept: modern fluid management in intensive care medicine].[ROSE概念：重症医学中的现代液体管理]
Med Klin Intensivmed Notfmed. 2024 Nov;119(8):634-639. doi: 10.1007/s00063-024-01193-1. Epub 2024 Oct 9.
2
Capillary refill time for the management of acute circulatory failure: a survey among pediatric and adult intensivists.毛细血管再充盈时间在急性循环衰竭管理中的应用：儿科和成人重症监护医师的调查。
BMC Emerg Med. 2022 Jul 18;22(1):131. doi: 10.1186/s12873-022-00681-x.
本文引用的文献
1
Effects of a Resuscitation Strategy Targeting Peripheral Perfusion Status versus Serum Lactate Levels among Patients with Septic Shock. A Bayesian Reanalysis of the ANDROMEDA-SHOCK Trial.以外周灌注状态为目标的复苏策略与脓毒性休克患者血清乳酸水平的影响。ANDROMEDA-SHOCK 试验的贝叶斯再分析。
Am J Respir Crit Care Med. 2020 Feb 15;201(4):423-429. doi: 10.1164/rccm.201905-0968OC.
2
Recruiting the microcirculation in septic shock.脓毒性休克中微循环的募集
Ann Intensive Care. 2019 Sep 11;9(1):102. doi: 10.1186/s13613-019-0577-9.
3
Acute Kidney Injury and Fluid Resuscitation in Septic Patients: Are We Protecting the Kidney?脓毒症患者的急性肾损伤与液体复苏：我们在保护肾脏吗？
Nephron. 2019;143(3):170-173. doi: 10.1159/000501748. Epub 2019 Aug 8.
4
Understanding Lactatemia in Human Sepsis. Potential Impact for Early Management.理解人类脓毒症中的乳酸性血症。早期管理的潜在影响。
Am J Respir Crit Care Med. 2019 Sep 1;200(5):582-589. doi: 10.1164/rccm.201812-2342OC.
5
It's time to talk about ditching statistical significance.是时候谈谈摒弃统计显著性了。
Nature. 2019 Mar;567(7748):283. doi: 10.1038/d41586-019-00874-8.
6
Effect of a Resuscitation Strategy Targeting Peripheral Perfusion Status vs Serum Lactate Levels on 28-Day Mortality Among Patients With Septic Shock: The ANDROMEDA-SHOCK Randomized Clinical Trial.以外周灌注状态为目标的复苏策略与血清乳酸水平对感染性休克患者 28 天死亡率的影响：ANDROMEDA-SHOCK 随机临床试验。
JAMA. 2019 Feb 19;321(7):654-664. doi: 10.1001/jama.2019.0071.
7
Optimal pressing strength and time for capillary refilling time.用于毛细血管再充盈时间的最佳按压强度和时间。
Crit Care. 2019 Jan 8;23(1):4. doi: 10.1186/s13054-018-2295-3.
8
Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial.体外膜肺氧合治疗严重急性呼吸窘迫综合征和一项随机临床试验事后贝叶斯分析中死亡率获益的后验概率。
JAMA. 2018 Dec 4;320(21):2251-2259. doi: 10.1001/jama.2018.14276.
9
Fluid volume, fluid balance and patient outcome in severe sepsis and septic shock: A systematic review.严重脓毒症和脓毒性休克患者的液体量、液体平衡和患者结局：系统评价。
J Crit Care. 2018 Dec;48:153-159. doi: 10.1016/j.jcrc.2018.08.018. Epub 2018 Aug 20.
10
The ten pitfalls of lactate clearance in sepsis.脓毒症中乳酸清除的十大陷阱
Intensive Care Med. 2019 Jan;45(1):82-85. doi: 10.1007/s00134-018-5213-x. Epub 2018 May 12.
Zotero 插件